Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina
Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical...
Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical...
ObvioHealth, a leading global Virtual Research Organization (VRO) delivering end-to-end decentralized clinical trial solutions, announces it has completed the first...